Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.
Researchers from the Washington University School of Medicine looked at the health outcomes among more than two million people taking the popular weight-loss medications.